Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

Anthony P.Y. Liu, Brian Gudenas, Tong Lin, Brent A. Orr, Paul Klimo, Rahul Kumar, Eric Bouffet, Sridharan Gururangan, John R. Crawford, Stewart J. Kellie, Murali Chintagumpala, Michael J. Fisher, Daniel C. Bowers, Tim Hassall, Daniel J. Indelicato, Arzu Onar-Thomas, David W. Ellison, Frederick A. Boop, Thomas E. Merchant, Giles W. RobinsonPaul A. Northcott, Amar Gajjar

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)'. Together they form a unique fingerprint.

Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

Fingerprint

Medicine & Life Sciences